Development of an ideal vaccine against pulmonary tuberculosis (TB) may require immunization strategies that generate a high frequency of antigen-specific CD4 and CD8 T cell response in the periphery and in the lung (Darrah et al., 2014). Here, CD4 is linked to tuberculosis.